Polaprezine is a complex compound formed by zinc and L-carnosine. Zinc is an ideal carrier for L-carnosine. The two produce a significant synergy.
Linezolid glucose injection is a synthetic oxazolidinone antibiotic. It is a bacterial protein synthesis inhibitor. It acts on the 50S ribosomal subunit of bacteria to prevent the formation of 70S initial complexes, thereby inhibiting the synthesis of bacterial protein. It is used to treat infections caused by gram-positive (G) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by MRSA, community-acquired pneumonia (CAP), complex skin or skin and soft tissue infections (SSTI), and resistant Vancomycin enterococcus infection, etc., and its safety is good, and it can be used from newborn babies to elderly patients, and its clinical application range is relatively wide. Linezolid glucose injection has more clinical application data and guideline recommendations, and is highly recognized by physicians.
Clopidogrel, as an ADP receptor antagonist, prevents ADP from binding to ADP receptors on platelets and prevents glycoprotein IIb/IIIa receptors from binding to fibrinogen, thereby inhibiting platelet aggregation. It is used to prevent and treat heart, brain and other arterial circulatory disorders caused by high platelet aggregation, such as recent strokes, myocardial infarction and confirmed peripheral arterial diseases.
